Monthly Archives: April 2009

DDMAC Mis-steps Badly and “Sows Confusion”

Last week, the New York Times carried an article "FDA Rules on Ads Sow Confusion as Applied to the Web" that addresses the call by the agency to issue 14 letters regarding 45 brands based on the lack of risk … Continue reading

Posted in DTC Advertising, FDA Policy | 4 Comments

Perspectives on DTC Perspectives

Yesterday I had the good fortune to participate on a panel staged at the National DTC Perspectives Conference held here in Washington.   The conference was impressive not only because of the size and scope of the turnout – hundreds … Continue reading

Posted in DTC Advertising, FDA Policy | 2 Comments

FDA Staffing Provides Insight into Future Changes Affecting DTC

This week it was announced that a senior fellow from the office of Senator Edward Kennedy would be heading back to FDA as a senior counselor to Dr. Joshua Sharfstein where it is reported that the FDA Office of Legislative … Continue reading

Posted in DTC Advertising, FDA Policy | Comments Off

A Conversation Around the Legal Questions About the FDA’s 14 Untitled Letters on Paid Search Ads

The issuance of the 14 untitled letters by the FDA a week ago Friday has been very troubling on a number of circumstances.  The agency accompanied the action that the letters were sent as part of "routine monitoring" which, unfortunately, … Continue reading

Posted in FDA Policy | 1 Comment

Weekly Roundup – 4/10/09

The cherry blossoms are done, but for some reason, the tourists are still sticking around Washington. The Administration continues to fill jobs, though frankly not at a fast enough rate, with the Secretary of HHS still unconfirmed as is the … Continue reading

Posted in Weekly Roundup | Comments Off